JP2008526893A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008526893A5 JP2008526893A5 JP2007550575A JP2007550575A JP2008526893A5 JP 2008526893 A5 JP2008526893 A5 JP 2008526893A5 JP 2007550575 A JP2007550575 A JP 2007550575A JP 2007550575 A JP2007550575 A JP 2007550575A JP 2008526893 A5 JP2008526893 A5 JP 2008526893A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- inhalable
- inhalable pharmaceutical
- patient
- insulin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US64305405P | 2005-01-10 | 2005-01-10 | |
| PCT/US2006/000910 WO2006086107A2 (en) | 2005-01-10 | 2006-01-10 | Methods and compositions for minimizing accrual of inhalable insulin in the lungs |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008526893A JP2008526893A (ja) | 2008-07-24 |
| JP2008526893A5 true JP2008526893A5 (cg-RX-API-DMAC7.html) | 2009-03-05 |
Family
ID=36793549
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007550575A Withdrawn JP2008526893A (ja) | 2005-01-10 | 2006-01-10 | 肺における吸入可能なインスリンの自然増加を最少化するための方法及び組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20060153778A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1858486A2 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2008526893A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2006213084A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2592776A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2007008379A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2006086107A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9006175B2 (en) * | 1999-06-29 | 2015-04-14 | Mannkind Corporation | Potentiation of glucose elimination |
| CA2377204C (en) | 1999-06-29 | 2015-01-20 | Pharmaceutical Discovery Corporation | Purification and stabilization of peptide and protein pharmaceutical agents |
| WO2003080149A2 (en) | 2002-03-20 | 2003-10-02 | Mannkind Corporation | Inhalation apparatus |
| US20070027063A1 (en) * | 2004-01-12 | 2007-02-01 | Mannkind Corporation | Method of preserving the function of insulin-producing cells |
| EP1786784B1 (en) | 2004-08-20 | 2010-10-27 | MannKind Corporation | Catalysis of diketopiperazine synthesis |
| CN104436170B (zh) | 2004-08-23 | 2018-02-23 | 曼金德公司 | 用于药物输送的二酮哌嗪盐 |
| AU2014271222B2 (en) * | 2005-09-14 | 2016-04-28 | Mannkind Corporation | Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents |
| IN2014DN09128A (cg-RX-API-DMAC7.html) | 2005-09-14 | 2015-07-10 | Mannkind Corp | |
| CN101389348A (zh) | 2006-02-22 | 2009-03-18 | 曼金德公司 | 用于改善包含二酮哌嗪和活性剂的微粒的药物性质的方法 |
| US8785396B2 (en) | 2007-10-24 | 2014-07-22 | Mannkind Corporation | Method and composition for treating migraines |
| HUE025485T2 (en) * | 2007-10-24 | 2016-02-29 | Mannkind Corp | Respiratory dry powder formulation containing GLP-1 for use in the treatment of hyperglycemia and diabetes by pulmonary administration |
| US20190262557A1 (en) * | 2010-03-04 | 2019-08-29 | Mannkind Corporation | Dry powder drug delivery system |
| CN109568740B (zh) | 2008-06-13 | 2022-05-27 | 曼金德公司 | 干粉吸入器和用于药物输送的系统 |
| US8485180B2 (en) | 2008-06-13 | 2013-07-16 | Mannkind Corporation | Dry powder drug delivery system |
| US9358352B2 (en) | 2008-06-13 | 2016-06-07 | Mannkind Corporation | Dry powder drug delivery system and methods |
| BR122020002400B1 (pt) | 2008-06-20 | 2021-12-07 | Mannkind Corporation | Sistema de detecção de inalação de pó seco e sistema de monitoramento acoplável para um inalador de pó seco |
| TWI614024B (zh) * | 2008-08-11 | 2018-02-11 | 曼凱公司 | 超快起作用胰島素之用途 |
| US11110151B2 (en) * | 2008-08-11 | 2021-09-07 | Mannkind Corporation | Composition and method for reducing hypoglycemia events in diabetes treatment |
| US8314106B2 (en) | 2008-12-29 | 2012-11-20 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
| JP5918539B2 (ja) * | 2009-01-08 | 2016-05-18 | マンカインド コーポレイション | Ｇｌｐ−１を用いる高血糖症の治療方法 |
| KR101733816B1 (ko) * | 2009-03-04 | 2017-05-08 | 맨카인드 코포레이션 | 개선된 건조 분말 약물 전달 시스템 |
| AU2014200960B2 (en) * | 2009-03-04 | 2016-02-11 | Mannkind Corporation | An improved dry powder drug delivery system |
| PL2405963T3 (pl) | 2009-03-11 | 2014-04-30 | Mannkind Corp | Urządzenie, układ i sposób pomiaru oporu inhalatora |
| ES2880102T3 (es) * | 2009-06-12 | 2021-11-23 | Mannkind Corp | Micropartículas de dicetopiperazina con contenido de isómeros definido |
| CA2764505C (en) | 2009-06-12 | 2018-09-25 | Mannkind Corporation | Diketopiperazine microparticles with defined specific surface areas |
| EP2496295A1 (en) | 2009-11-03 | 2012-09-12 | MannKind Corporation | An apparatus and method for simulating inhalation efforts |
| JP6133270B2 (ja) | 2011-04-01 | 2017-05-24 | マンカインド コーポレイション | 薬剤カートリッジのためのブリスター包装 |
| WO2012174472A1 (en) | 2011-06-17 | 2012-12-20 | Mannkind Corporation | High capacity diketopiperazine microparticles |
| HK1201475A1 (en) | 2011-10-24 | 2015-09-04 | Mannkind Corporation | Methods and compositions for treating pain |
| CA2878457C (en) | 2012-07-12 | 2021-01-19 | Mannkind Corporation | Dry powder drug delivery systems and methods |
| EP2911690A1 (en) | 2012-10-26 | 2015-09-02 | MannKind Corporation | Inhalable influenza vaccine compositions and methods |
| MX392016B (es) | 2013-03-15 | 2025-03-21 | Mannkind Corp | Composiciones de dicetopiperazina microcristalina y métodos. |
| EP3021834A1 (en) | 2013-07-18 | 2016-05-25 | MannKind Corporation | Heat-stable dry powder pharmaceutical compositions and methods |
| JP2016530930A (ja) | 2013-08-05 | 2016-10-06 | マンカインド コーポレイション | 通気装置及び方法 |
| US10307464B2 (en) | 2014-03-28 | 2019-06-04 | Mannkind Corporation | Use of ultrarapid acting insulin |
| US10561806B2 (en) | 2014-10-02 | 2020-02-18 | Mannkind Corporation | Mouthpiece cover for an inhaler |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2000301A (en) * | 1932-04-02 | 1935-05-07 | Norman Confections Inc | Progressive container |
| US5352461A (en) * | 1992-03-11 | 1994-10-04 | Pharmaceutical Discovery Corporation | Self assembling diketopiperazine drug delivery system |
| US5888477A (en) * | 1993-01-29 | 1999-03-30 | Aradigm Corporation | Use of monomeric insulin as a means for improving the bioavailability of inhaled insulin |
| US5547929A (en) * | 1994-09-12 | 1996-08-20 | Eli Lilly And Company | Insulin analog formulations |
| US6428771B1 (en) * | 1995-05-15 | 2002-08-06 | Pharmaceutical Discovery Corporation | Method for drug delivery to the pulmonary system |
| CA2377204C (en) * | 1999-06-29 | 2015-01-20 | Pharmaceutical Discovery Corporation | Purification and stabilization of peptide and protein pharmaceutical agents |
| ES2584867T3 (es) * | 2004-01-12 | 2016-09-29 | Mannkind Corporation | Un método que reduce los niveles séricos de proinsulina en diabéticos de tipo 2 |
-
2006
- 2006-01-10 US US11/330,427 patent/US20060153778A1/en not_active Abandoned
- 2006-01-10 AU AU2006213084A patent/AU2006213084A1/en not_active Abandoned
- 2006-01-10 MX MX2007008379A patent/MX2007008379A/es unknown
- 2006-01-10 CA CA002592776A patent/CA2592776A1/en not_active Abandoned
- 2006-01-10 JP JP2007550575A patent/JP2008526893A/ja not_active Withdrawn
- 2006-01-10 EP EP06748159A patent/EP1858486A2/en not_active Withdrawn
- 2006-01-10 WO PCT/US2006/000910 patent/WO2006086107A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008526893A5 (cg-RX-API-DMAC7.html) | ||
| Shankar et al. | Isoflurane therapy for severe refractory status asthmaticus in children | |
| Diaz et al. | Delivery and safety of inhaled interferon-γ in idiopathic pulmonary fibrosis | |
| JP2008534622A5 (cg-RX-API-DMAC7.html) | ||
| JP2015110631A5 (cg-RX-API-DMAC7.html) | ||
| JP2011500850A5 (cg-RX-API-DMAC7.html) | ||
| JP2010522212A5 (cg-RX-API-DMAC7.html) | ||
| Morán et al. | Heat and moisture exchangers and heated humidifiers in acute lung injury/acute respiratory distress syndrome patients. Effects on respiratory mechanics and gas exchange | |
| YU36302A (sh) | Novi tiotropiumski preparati - koji sadrže prah za inhaliranje | |
| AR067639A1 (es) | Medicamentos pulverulentos que contienen tiotropio y salmetrol, asi como lactosa como excipiente | |
| WO2006059108A3 (en) | ANTI-IL-IRl SINGLE DOMAIN ANTIBODIES AND THERAPEUTIC USES | |
| MXPA03011861A (es) | Particulas para inhalacion que tienen rapidas propiedades de liberacion. | |
| JP2007520506A5 (cg-RX-API-DMAC7.html) | ||
| JP2007520507A5 (cg-RX-API-DMAC7.html) | ||
| Eden et al. | Prolonged smoldering Douglas fir smoke inhalation augments respiratory resistances, stiffens the aorta, and curbs ejection fraction in hypercholesterolemic mice | |
| Brain | Unlocking the opportunity of tight glycaemic control: Inhaled insulin: safety | |
| CN102133319B (zh) | 一种平喘止咳的药物及其制备方法 | |
| WO2005041922A3 (en) | Composition | |
| BR0316343A (pt) | Formulações pulverulentas para inalação contendo tiotrópio | |
| ATE339951T1 (de) | Pulverzubereitungen zur inhalation | |
| WO2007046113A3 (en) | Novel pharmaceutical composition comprising alkaloid and process thereof | |
| Scott et al. | Tongue swelling complicating management of a ventilated patient with acute respiratory distress syndrome secondary to novel influenza A (H1N1) | |
| JP2017524732A5 (cg-RX-API-DMAC7.html) | ||
| Hall | Wearing a noseclip improves nebulised aerosol delivery | |
| Spencer et al. | 1152 The Case of the Auto-PAP that did not Work |